Jump to Main Contents

Home > Organization > Divisions and Independent Research Units > Group for Translational Research > Division of Cancer Pathophysiology

Division of Cancer Pathophysiology


Research Activities

Since its establishment in January 2009, the Division of Cancer Pathophysiology has focused on two major research issues regarding 1) the improvement of the quality of life (QOL) of patients with cancer suffering from severe or intolerable pain, and 2) the prevention and development of novel treatments for cancer cachexia symptoms and chemotherapy-induced side effects in cancer patients. Based on the 2nd Basic Plan to Promote Cancer Control Programs in 2012, and the prospective 3rd plan in 2017, basic to clinical, and also clinical to basic translational collaborative research with the clinical laboratory groups comprises our main research protocols and has been ongoing. Since 2015, the Chief of this division holds both the posts in Exploratory Oncology Research and Clinical Trial Center (for phase I clinical study) and Innovation Center for Supportive, Palliative and Psychosocial Care (for phase II and III clinical studies), to accelerate the development of innovative medicines for cancer patients.